Doranidazole

DB17304ExperimentalSmall molecule

Doranidazole: Overview.

Chemical structure of Doranidazole
Mechanism
Curator reviewed
Formula / weight
C8H13N3O6 · 247.207 g/mol (avg)
Also known as
(2rs,3sr)-3-((2-nitroimidazol-1-yl)methoxy)butane-1,2,4-triol · 1,2,4-butanetriol, 3-((2-nitro-1h-imidazol-1-yl)methoxy)-, (2r,3s)-rel-
Code names
PR-350 · RP-343

Resolves to

Compound
UNII4BLU68P76ACAS149838-23-3ChEMBLCHEMBL2107741
Structure
InChIKeyFIITXXIVUIXYMI-RQJHMYQMSA-NSMILESOC[C@@H](O)[C@H](CO)OCN1C=CN=C1[N+]([O-])=O

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Doranidazole, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In